Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock
SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.24−0.29 (-6.40%)
Close on Nov 16, 2026Market cap $4.24MP/E –Yield –
Shuttle Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Shuttle Pharmaceuticals's cash was $90.24K at Jun 30, 2026. For fiscal 2025 it was $334.01K, down 82.6% from the year before. The highest annual figure on record is $8.42M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $334.01K | -82.6% |
| FY2024 | Dec 31, 2024 | $1.92M | -64.9% |
| FY2023 | Dec 31, 2023 | $5.46M | -35.1% |
| FY2022 | Dec 31, 2022 | $8.42M | +1567.6% |
| FY2021 | Dec 31, 2021 | $504.75K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $90.24K | -98.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.09M | -75.8% |
| Q4 FY2025 | Dec 31, 2025 | $334.01K | -82.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.09M | +1237.1% |
| Q2 FY2025 | Jun 30, 2025 | $4.82M | +106.0% |
| Q1 FY2025 | Mar 31, 2025 | $4.51M | +7.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.92M | -64.9% |
| Q3 FY2024 | Sep 30, 2024 | $156.66K | -97.7% |
| Q2 FY2024 | Jun 30, 2024 | $2.34M | -72.0% |
| Q1 FY2024 | Mar 31, 2024 | $4.19M | -58.8% |
| Q4 FY2023 | Dec 31, 2023 | $5.46M | -35.1% |
| Q3 FY2023 | Sep 30, 2023 | $6.81M | -25.4% |
| Q2 FY2023 | Jun 30, 2023 | $8.35M | +1554.5% |
| Q1 FY2023 | Mar 31, 2023 | $10.16M | – |
| Q4 FY2022 | Dec 31, 2022 | $8.42M | – |
| Q3 FY2022 | Sep 30, 2022 | $9.12M | – |
| Q4 FY2021 | Dec 31, 2021 | $504.75K | – |
See a number that looks wrong?